Medical Examination and Clinical Diagnosis

Predictive value of CD3+/CD4+T lymphocyte level and neutrophil to lymphocyte ratio in radiation pneumonia

  • Xinpan LI ,
  • Yi FANG ,
  • Jun QIU
Expand
  • *.Department of Tumor Ward 2,the First Affiliated Hospital of Hu′nan Normal University(Hu′nan Provincial People's Hospital),Changsha 410016,Hu′nan,China

Received date: 2024-06-24

  Online published: 2024-11-05

Abstract

Objective To investigate the predictive value of CD3+/CD4+T lymphocyte level and neutrophil to lymphocyte ratio (NLR) in radiation pneumonia. Methods The data of 87 patients with locally advanced non-operative non-small cell lung cancer admitted to our hospital from March 2018 to October 2023 were retrospectively analyzed. Among them, 43 cases had radiation pneumonia and 44 cases did not have radiation pneumonia. The changes in T lymphocyte subsets and NLR before and after radiotherapy were compared between the two groups. The diagnostic value of T lymphocyte subsets and NLR in lung cancer radiation pneumonia after radiotherapy was analyzed, the correlation between T lymphocyte subsets and NLR and the grade severity of radiation pneumonia was analyzed, and the ROC curve of T lymphocyte subsets and NLR in predicting lung cancer radiation pneumonia after radiotherapy was drawn, and the AUC area was calculated. Results The levels of CD3+T lymphocytes and CD4+T lymphocytes in the post-radiotherapy group were significantly lower than those before radiotherapy and those without radiotherapy (P < 0.05). The NLR in the post-radiotherapy group was significantly higher than that before radiotherapy and those without radiotherapy (P < 0.05). The sensitivity, specificity, accuracy, negative predictive value, and positive predictive value of the combined diagnosis of CD3+T lymphocytes, CD4+T lymphocytes, and NLR were higher than those of NLR and higher than those of CD4+T lymphocytes and CD3+T lymphocytes. The changes of CD3+T lymphocyte and CD4+T lymphocyte levels were negatively correlated with grade severity of radiopneumonia (P < 0.05), while the changes of NLR were positively correlated with grade severity of radiopneumonia (P < 0.05). Combined detection of CD3+T lymphocytes, CD4+T lymphocytes, and NLR predicted that the AUC area of lung cancer after radiotherapy was 0.924, which was larger than that of CD3+T lymphocytes, CD4+T lymphocytes, and NLR alone. Conclusion The combined detection of CD3+T lymphocytes, CD4+T lymphocytes, and NLR has an ideal value in the diagnosis and prediction of radiation pneumonia after radiotherapy for locally advanced non-small cell lung cancer, and can be used as an indicator for early diagnosis and prevention of radiation pneumonia.

Cite this article

Xinpan LI , Yi FANG , Jun QIU . Predictive value of CD3+/CD4+T lymphocyte level and neutrophil to lymphocyte ratio in radiation pneumonia[J]. The Journal of Practical Medicine, 2024 , 40(20) : 2923 -2928 . DOI: 10.3969/j.issn.1006-5725.2024.20.017

References

1 吴华玲,林清. 乳腺癌调强放疗后放射性肺炎的临床和剂量学相关因素分析[J]. 中国癌症防治杂志,2024,16(3): 327-331.
2 孙振伟,王晨,陈梦,等. 局部晚期非小细胞肺癌自适应放化疗后PD-1抑制剂巩固治疗的征招挑战[J]. 肿瘤学杂志,2024,30(3): 193-199.
3 瞿发林,李耀光,翟玉龙,等. TLR9基因SNP与肺癌放疗患者放射性肺炎发生风险的关联分析[J]. 空军航空医学,2023,40 (2): 150-155.
4 刘维鹏,朱青山,冯连杰,等. 中性粒细胞与淋巴细胞比值、白细胞介素-17A及转化生长因子-β对局部晚期非小细胞肺癌患者发生放射性肺炎的诊断价值[J]. 癌症进展,2022,20(3): 282-285.
5 吴侃,杨邵瑜,徐晓,等. C反应蛋白联合中性粒细胞数预测容积旋转调强放疗后急性放射性肺炎的临床研究[J]. 实用肿瘤杂志,2018,33(5): 450-454.
6 CURRAS-ALONSO S, SOULIER J, DEFARD T, et al. An interactive murine single-cell atlas of the lung responses to radiation injury[J].Nat Commun, 2023, 14(1):2445. doi:10.1038/s41467-023-38134-z
7 KALISZ K R, RAMAIYA N H, LAUKAMP K R, et al. Immune Checkpoint Inhibitor Therapy-related Pneumonitis: Patterns and Management[J]. Radiographics, 2019, 39(7):1923-1937. doi:10.1148/rg.2019190036
8 YING H, FANG M, HANG Q Q, et al. Pirfenidone modulates macrophage polarization and ameliorates radiation-induced lung fibrosis by inhibiting the TGF-beta1/Smad3 pathway[J]. J Cell Mol Med, 2021, 25(18):8662-8675. doi:10.1111/jcmm.16821
9 ZHANG Z, ZHOU J, VERMA V, et al. Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury[J]. Front Immunol, 2021, 12(1):774807. doi:10.3389/fimmu.2021.774807
10 王静, 孙旭, 易宣洪, 等. 清燥救肺汤联合痰热清注射液防治放射性肺损伤的临床疗效及对免疫指标、IL-2和TNF-α表达的影响[J]. 中医肿瘤学杂志, 2024, 6(1): 43-48.
11 庞然然. 剂量体积参数及CRP与食管癌放疗后放射性肺炎的相关性[J]. 实用癌症杂志, 2023, 38(9): 1540-1543.
12 杨蜜, 张欣平, 张加勇, 等. 调强放射治疗下老年食管癌症状性急性放射性肺炎发生的相关因素[J]. 中国老年学杂志, 2023, 43(14): 3374-3378.
13 崔晶娴, 董业峰, 陈烨, 等. 血清CD4+/CD8+、PCT及KL-6水平与局部晚期NSCLC放疗后放射性肺炎严重程度的相关性研究[J]. 转化医学杂志, 2022, 11(6): 384-387.
14 王敬才,郭春艳,杨丽昕,等. 血清RAGE、HMGB1水平与重症肺炎急性呼吸窘迫综合征发病及IFN-γ/IL-4变化的关系[J].实用医学杂志,2024,40(4):515-520.
15 刘维鹏, 朱青山, 冯连杰, 等. 中性粒细胞与淋巴细胞比值、白细胞介素-17A及转化生长因子-β对局部晚期非小细胞肺癌患者发生放射性肺炎的诊断价值[J]. 癌症进展, 2022, 20 (3): 282-285.
16 武道荣,闫雪波,闻婷玉,等. 血清及下呼吸道分泌物SLPI水平在ICU重症肺炎中的评估价值[J]. 实用医学杂志,2023,39(12):1529-1535.
17 吴侃, 徐晓, 张敏娜, 等. 容积旋转调强放疗后免疫功能变化及对急性放射性肺炎预测价值的研究[J]. 浙江临床医学, 2018, 20(11): 1776-1778.
18 陈不尤, 王伟, 肖明兵, 等. 抗放射性肺炎方对放射性肺损伤大鼠免疫功能的影响[J]. 中国实验方剂学杂志, 2012, 18 (24): 248-251.
19 张思琪, 邓丽霞, 赵青莲, 等. 肺癌患者接受放疗和免疫治疗后引发放射召回性肺炎的研究[J]. 癌症进展, 2023, 21(10):1062-1064,1113.
20 YIN J, WU Y, YANG X, et al. Checkpoint Inhibitor Pneumonitis Induced by Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer: Occurrence and Mechanism[J]. Front Immunol, 2022, 13(7):830631. doi:10.3389/fimmu.2022.830631
Outlines

/